Peer Review History
| Original SubmissionMay 12, 2025 |
|---|
|
Dear Dr. Soorni, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammad Faezi Ghasemi, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Bacillus spizizenii (formerly classified under B.subtilis [Note: HTML markup is below. Please do not edit.] Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The manuscript presents a well-structured and clearly written study with a sound experimental design. The authors have successfully combined microbiological isolation, enzymatic characterization, phylogenetic analysis, and in silico modeling to investigate alpha-amylase-producing Bacillus strains. The objectives are well-defined, the methods are generally appropriate, and the overall flow of the manuscript supports comprehension. However, a number of clarifications, methodological details, and data inconsistencies need to be addressed to improve the manuscript’s scientific rigor, reproducibility, and alignment with standard academic practices. 1. Confirmation of Vegetative Cell Contribution to Enzyme Production The study identifies four Bacillus strains, which are capable of spore formation. It is unclear how the authors confirmed that the observed enzyme stability across a broad pH range and temperatures is attributed to vegetative cells rather than spores. Since the enzyme was extracted from culture supernatants, it is possible that the secreted enzymes were produced before sporulation. Clarification on the timing of enzyme harvest relative to the bacterial growth phase is recommended. 2. Cultivation Temperature The authors used a cultivation temperature of 37°C during the enzyme activity assay. Given that the strains were isolated from environmental sources, why was this temperature selected instead of 30°C, which is more typical for environmental Bacillus species? 3. Negative Control for α-Amylase Activity While the manuscript mentions the use of a negative control for α-amylase production, the nature of this control is not specified. Please provide details regarding the strain or condition used as the negative control. 4. DNS Assay – Absorbance Wavelength The DNS method is typically measured at 540 nm, but the authors report measurements at 660 nm. Please clarify whether this is a methodological adaptation or an error. 5. Dialysis Procedure The molecular weight cutoff (MWCO) of the dialysis membrane used is not specified. This information is essential for reproducibility and should be included. 6. Centrifugation Speed Reporting The manuscript reports centrifugation at 15,000 rpm, whereas elsewhere, centrifugal force is expressed in ×g. For consistency, all centrifugation speeds should be presented in relative centrifugal force (RCF, ×g). Additionally, labeling this step as “high-speed centrifugation” would improve clarity. 7. Docking Study – Gene or Protein? The text states that docking was used to “evaluate the interaction dynamics between the alpha-amylase gene and its respective ligand molecules.” Docking is typically performed at the protein level, not the gene level. Please clarify whether the docking analysis was conducted using the predicted 3D structure of the alpha-amylase protein, as expected. 8. Missing Method Section: Growth Pattern and Enzyme Activity The methods used to study growth pattern and amylase activity are described in the Results section but not in the Methods. To improve clarity and organization, this section should be moved or referenced properly within the Methods. 9. Selective Culture Medium Composition The ingredients or selective agents used in the “selective culture medium” are not described. Please include full composition and purpose of the medium. 10. Initial Maltose Concentration The initial maltose concentration in the culture medium is not reported, which is essential for evaluating substrate reduction and enzyme efficiency. 11. Discrepancy Between Text and Figure 2A The text states that "strain S1 surpassed S3 in enzyme activity at 50°C and pH 7," but Figure 2A shows strain S3 having the highest activity at that point. Please resolve this inconsistency. 12. Inconsistency Between Figures 2A and 2B The enzyme activity patterns in Figures 2A and 2B appear to differ. For example, S3 maintains high activity at 70°C in 2A, while the top activity at that temperature in 2B appears to belong to S1. Clarification or correction is needed. 13. Missing rpoB Primer Sequences The primer sequences used for amplifying the rpoB gene are not provided. These should be included for transparency and reproducibility. 14. Missing Reference or Sequences for 16S rRNA Primers No reference or sequence information is given for the 16S rRNA primers. Please add this to the manuscript. 15. Missing SDS-PAGE Results Although protein extraction and purification are discussed, the SDS-PAGE results (e.g., molecular weight confirmation) are not presented. These are standard for enzyme characterization and should be included. 16. No Presentation of α-Amylase Gene Sequence The nucleotide or amino acid sequence of the alpha-amylase gene under investigation is not shown. Inclusion of this data would strengthen the study and allow for future comparison. 17. Missing GOR4 Analysis Data While the GOR4 tool is mentioned for secondary structure prediction, the results of this analysis are not included. Please add the relevant data or images. 18. Missing 3D Structure Validation Data The manuscript states that the 3D structure was validated, but does not provide Ramachandran plots, ERRAT, or Verify3D outputs. These are essential for validating structural models and should be included in the supplementary materials or main text. 19. Missing Strain Location Information The geographical origin or sampling location of strains S1, S3, S4, and S5 is not mentioned. Including this information would provide important ecological and contextual relevance to the study. Reviewer #2: Questions for the Corresponding Author 1. You report the enzyme activity as high as 34,121 U/g. Can you provide the exact experimental setup, replicates, and error margins that support this claim? How was U/g converted from absorbance? 2. Why was there no use of enzyme kinetics (Km, Vmax) or substrate specificity testing to confirm functional superiority over existing α-amylases? 3. What mechanistic evidence supports the claimed thermostability and pH stability of the enzyme beyond in vitro activity measurements (e.g., structural analysis or melting temperature assays)? 4. Did you validate the AlphaFold2-predicted structure experimentally (e.g., CD spectroscopy, crystallography)? How do you confirm that the docking simulations are biologically meaningful? 5. Your docking analysis shows -8.4 kcal/mol affinity for maltotetraose. Did you perform validation using known inhibitors or competitive ligands to assess docking reliability? 6. Given that B. spizizenii was previously classified under B. subtilis, what molecular markers (e.g., ANI, dDDH, or pan-genome features) unequivocally separate your isolates from known strains? 7. Why was 16S rRNA used for taxonomic classification, despite its known limitations in distinguishing Bacillus species? Why not employ multi-locus sequence analysis (MLSA)? 8. What genomic features or genes in the B. spizizenii strains contribute to the thermal and pH tolerance beyond the α-amylase gene itself? 9. Was the gene copy number of α-amylase determined in the genome? Could gene dosage explain the high production rate? 10. How do you address potential codon bias or expression bottlenecks if the gene were to be heterologously expressed in a commercial host? 11. Was there any testing for protease resistance, a critical property for feed industry applications, especially in the digestive tract environment? 12. How reproducible were the enzyme activities across biological replicates? Did you test enzyme production in different batches or fermentation conditions? 13. You mention SDS-PAGE analysis. Was the band at ~62 kDa verified by mass spectrometry or western blot to confirm its identity as α-amylase? 14. How were protein concentrations normalized across strains when comparing enzyme activity? Was Bradford or BCA assay used? 15. You suggest these enzymes are suitable for animal feed processing. Did you test enzyme activity under simulated gastric conditions (e.g., pH 2 + pepsin)? 16. Your phylogenetic tree is based on 16S and rpoB sequences. Why not include whole-genome-based phylogeny for higher resolution? 17. Were mobile genetic elements or plasmids present in the genomes that might encode the α-amylase or other industrially useful traits? 18. You performed docking with maltotriose and maltotetraose. Why not validate these findings using enzyme-substrate kinetics to correlate in silico and in vitro results? 19. In the enzyme purification step, what was the specific activity at each stage (crude, ammonium sulfate, dialysis)? 20. How do you account for the discrepancy in molecular weights of your α-amylase (~62 kDa) and commonly reported α-amylases from Bacillus species (typically ~55 kDa)? 21. You reference strong ANOVA significance; was the data distribution checked for normality and homoscedasticity before applying ANOVA? 22. Have you performed codon usage analysis for the α-amylase gene, and how compatible is it with common expression systems like E. coli, Pichia, or Bacillus subtilis? Comments for the Authors 1. The manuscript lacks mechanistic insight into how the observed thermostability and pH tolerance arise at the structural level—consider modeling or mutagenesis to identify stabilizing residues. 2. The docking study lacks dynamic validation; a 50–100 ns molecular dynamics simulation could significantly enhance credibility of the ligand binding data. 3. The statistical rigor is unclear—multiple ANOVAs were used, but there’s no mention of corrections for multiple testing (e.g., Bonferroni, Holm). This may inflate Type I error. 4. Figures and supplementary tables (S1–S7) are referenced heavily for critical findings but are not integrated into the main text for interpretation. Include key statistical outputs in the main manuscript. 5. Although you refer to your strains as ‘novel,’ ANI and DDH values suggest high similarity to known strains. The novelty claim needs deeper genomic comparisons (e.g., accessory gene analysis). 6. Gene ontology or functional annotation of the full genomes is missing—an enrichment analysis would provide insight into other industrially useful enzymes. 7. The use of 16S and rpoB alone is insufficient for species-level resolution within the Bacillus subtilis complex. Whole-genome or MLST would strengthen taxonomic claims. 8. You describe high enzyme activity in U/g, but no volumetric productivity (U/L/h) or yield (% starch converted) is given—important for industrial comparison. 9. The SDS-PAGE result is descriptive, but lacking quantitative analysis (e.g., densitometry, purity level) or validation of identity—needs enhancement. 10. Discussion compares your strains with others, but lacks quantitative benchmarking. Include a comparative table with literature values for α-amylase productivity and stability. 11. The methods do not clarify whether pH/temperature stability assays were carried out over time (e.g., half-life at 70°C), which is more relevant than just endpoint activity. 12. There is no evidence presented that the enzyme can function in real-world matrices (e.g., feed pellets, animal digestive fluid simulations). 13. You note broad thermal tolerance, but did not evaluate thermostability after multiple freeze-thaw cycles or storage at room temperature. 14. The manuscript would benefit from a summary schematic illustrating strain isolation, screening, characterization, sequencing, and application potential. 15. The conclusion lacks detail on limitations and future work. Suggest specifying next steps such as expression in industrial hosts, pilot-scale fermentation, or enzyme immobilization. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Soorni, plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammad Faezi Ghasemi, Ph.D Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear respected Authors, Based on the advice received from our reviewers, I have decided that your manuscript requires minor revision. Please review the reviewers' comments and submit your revised version. Editor's Comment: In my initial feedback, I requested that you specify the exact location of your isolation in the title. Thank you for adding "Isfahan province" in your revised version. I have noticed that you also screened samples from other provinces. Therefore, please clarify that you tested environmental samples from various provinces across Iran and that the best-performing strains were those isolated from Isfahan province (please include their specific code numbers). This information should be added to both the abstract and the materials and methods sections. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: All comments have been addressed appropriately, except for the following two points: Please provide Gram-staining images (if available) to verify and demonstrate the presence or absence of vegetative cells under the different conditions applied in the enzymatic assay. It is essential to include the results of the negative control and integrate them into both the statistical analysis and the graphical representations of enzyme activity. This will ensure that the potential effect of starch auto-degradation in the culture medium is appropriately accounted for and not overlooked. Addressing these points will further improve the clarity and reliability of the manuscript. Reviewer #2: I would like to thank the authors for their thorough and constructive revisions in response to my detailed comments. The clarifications regarding sampling rationale, enzyme activity units, statistical rigor, and genomic analyses were well addressed. Figures and tables are now clearer, and the discussion has been strengthened with appropriate comparisons to previous studies. The manuscript provides important insights into α-amylase-producing Bacillus spizizenii strains from Iran, and I believe it will be of broad interest to the readership. I have no further concerns, and I support acceptance of this work. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Genomic and enzymatic insights into α-amylase-producing Bacillus spizizenii strains isolated from Isfahan province, Iran PONE-D-25-25544R2 Dear Dr. Soorni, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammad Faezi Ghasemi, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewer #1: Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: I would like to thank the author(s) for their comprehensive and clear responses to all the comments and concerns I raised during the review process. The revisions have been addressed appropriately. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-25544R2 PLOS ONE Dear Dr. Soorni, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammad Faezi Ghasemi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .